+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Long-acting Contraception Market by Type (Long-Acting Contraceptives, Short-Acting Contraceptives), Product (Injectables, Intrauterine Devices, Subdermal Implants), Application, End-use - Forecast 2024-2030- Product Image
Global Long-acting Contraception Market by Type (Long-Acting Contraceptives, Short-Acting Contraceptives), Product (Injectables, Intrauterine Devices, Subdermal Implants), Application, End-use - Forecast 2024-2030- Product Image
Sale

Global Long-acting Contraception Market by Type (Long-Acting Contraceptives, Short-Acting Contraceptives), Product (Injectables, Intrauterine Devices, Subdermal Implants), Application, End-use - Forecast 2024-2030

  • PDF Icon

    Report

  • 191 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5715566
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Long-acting Contraception Market size was estimated at USD 3.42 billion in 2023, USD 3.68 billion in 2024, and is expected to grow at a CAGR of 7.06% to reach USD 5.52 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Long-acting Contraception Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Long-acting Contraception Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Long-acting Contraception Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Bayer AG, DKT International, HRA Pharma SAS by Perrigo Company plc, Merck & Co., Inc., Meril Life Sciences Pvt. Ltd., Mona Lisa N.V., OCON Healthcare, Pfizer Inc., Pregna International Limited, Prosan International B.V., SMB Corporation of India, Teva Pharmaceuticals Industries Ltd., The Cooper Companies, Inc., and Viatris Inc.

Market Segmentation & Coverage

This research report categorizes the Long-acting Contraception Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Long-Acting Contraceptives
    • Short-Acting Contraceptives
  • Product
    • Injectables
    • Intrauterine Devices
    • Subdermal Implants
  • Application
    • Contraception
    • HIV
    • Schizophrenia
  • End-use
    • Drug Store
    • E-Commerce
    • Hospital
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Long-acting Contraception Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Long-acting Contraception Market?
  3. What are the technology trends and regulatory frameworks in the Long-acting Contraception Market?
  4. What is the market share of the leading vendors in the Long-acting Contraception Market?
  5. Which modes and strategic moves are suitable for entering the Long-acting Contraception Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Long-acting Contraception Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising adoption of long term contraception among male and female
5.1.1.2. Rising publicly funded family planning services
5.1.2. Restraints
5.1.2.1. Associated side effects of long term contraception
5.1.3. Opportunities
5.1.3.1. Introduction of technically advanced long term contraception methods
5.1.3.2. Strong government support for LTC
5.1.4. Challenges
5.1.4.1. Concern regarding limited approved products
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Long-acting Contraception Market, by Type
6.1. Introduction
6.2. Long-Acting Contraceptives
6.3. Short-Acting Contraceptives
7. Long-acting Contraception Market, by Product
7.1. Introduction
7.2. Injectables
7.3. Intrauterine Devices
7.4. Subdermal Implants
8. Long-acting Contraception Market, by Application
8.1. Introduction
8.2. Contraception
8.3. HIV
8.4. Schizophrenia
9. Long-acting Contraception Market, by End-use
9.1. Introduction
9.2. Drug Store
9.3. E-Commerce
9.4. Hospital
10. Americas Long-acting Contraception Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Long-acting Contraception Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Long-acting Contraception Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. AbbVie Inc.
14.1.2. Bayer AG
14.1.3. DKT International
14.1.4. HRA Pharma SAS by Perrigo Company plc
14.1.5. Merck & Co., Inc.
14.1.6. Meril Life Sciences Pvt. Ltd.
14.1.7. Mona Lisa N.V.
14.1.8. OCON Healthcare
14.1.9. Pfizer Inc.
14.1.10. Pregna International Limited
14.1.11. Prosan International B.V.
14.1.12. SMB Corporation of India
14.1.13. Teva Pharmaceuticals Industries Ltd.
14.1.14. The Cooper Companies, Inc.
14.1.15. Viatris Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. LONG-ACTING CONTRACEPTION MARKET RESEARCH PROCESS
FIGURE 2. LONG-ACTING CONTRACEPTION MARKET SIZE, 2023 VS 2030
FIGURE 3. LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. LONG-ACTING CONTRACEPTION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. LONG-ACTING CONTRACEPTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. LONG-ACTING CONTRACEPTION MARKET DYNAMICS
FIGURE 7. LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 10. LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 14. LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. LONG-ACTING CONTRACEPTION MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. LONG-ACTING CONTRACEPTION MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. LONG-ACTING CONTRACEPTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. LONG-ACTING CONTRACEPTION MARKET SIZE, BY LONG-ACTING CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. LONG-ACTING CONTRACEPTION MARKET SIZE, BY SHORT-ACTING CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 9. LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. LONG-ACTING CONTRACEPTION MARKET SIZE, BY SUBDERMAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. LONG-ACTING CONTRACEPTION MARKET SIZE, BY CONTRACEPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. LONG-ACTING CONTRACEPTION MARKET SIZE, BY HIV, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. LONG-ACTING CONTRACEPTION MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 17. LONG-ACTING CONTRACEPTION MARKET SIZE, BY DRUG STORE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. LONG-ACTING CONTRACEPTION MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 33. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 37. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 55. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 59. INDIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. INDIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. INDIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. INDIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 67. JAPAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. JAPAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. JAPAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. JAPAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 91. THAILAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. THAILAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. THAILAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. THAILAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 108. EGYPT LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. EGYPT LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. EGYPT LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. EGYPT LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 112. FINLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. FINLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. FINLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. FINLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 116. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 120. GERMANY LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. GERMANY LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. GERMANY LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 128. ITALY LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. ITALY LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. ITALY LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. ITALY LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 140. NORWAY LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. NORWAY LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. NORWAY LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. NORWAY LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 144. POLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. POLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. POLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. POLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 148. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 164. SPAIN LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. SPAIN LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SPAIN LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 176. TURKEY LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. TURKEY LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. TURKEY LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. TURKEY LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 188. LONG-ACTING CONTRACEPTION MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 189. LONG-ACTING CONTRACEPTION MARKET SHARE, BY KEY PLAYER, 2023
TABLE 190. LONG-ACTING CONTRACEPTION MARKET LICENSE & PRICING

Companies Mentioned

  • AbbVie Inc.
  • Bayer AG
  • DKT International
  • HRA Pharma SAS by Perrigo Company plc
  • Merck & Co., Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Mona Lisa N.V.
  • OCON Healthcare
  • Pfizer Inc.
  • Pregna International Limited
  • Prosan International B.V.
  • SMB Corporation of India
  • Teva Pharmaceuticals Industries Ltd.
  • The Cooper Companies, Inc.
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.68 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.52 Billion
Compound Annual Growth Rate7.0%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Female Contraceptive - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Female Contraceptive - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 112 Pages
  • Global
From
Global Female Contraceptive Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Global Female Contraceptive Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 190 Pages
  • Global
From
Global Contraceptive Pills Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Global Contraceptive Pills Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 190 Pages
  • Global
From
Female Contraception Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Female Contraception Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 86 Pages
  • Global
From
Global Contraceptive Market by Product (Devices, Drugs), Gender (Female Contraceptive, Male Contraceptive), Method, Distribution - Forecast 2024-2030 - Product Image

Global Contraceptive Market by Product (Devices, Drugs), Gender (Female Contraceptive, Male Contraceptive), Method, Distribution - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From

About the Long Acting Contraception Market

The Long Acting Contraception market is a subset of the Personal Care Products industry. It includes a variety of products designed to provide long-term contraception, such as intrauterine devices (IUDs), contraceptive implants, and injectable contraceptives. These products are designed to provide a safe and effective form of contraception for women who wish to avoid pregnancy. Long Acting Contraception products are typically used by women who are looking for a more reliable form of contraception than traditional methods, such as the pill or condoms. They are also used by women who are looking for a more convenient form of contraception, as they do not require daily or weekly use. The Long Acting Contraception market is highly competitive, with a number of companies offering products. Some of the major players in the market include Bayer, Merck, Allergan, and Teva Pharmaceuticals. These companies offer a variety of products, ranging from IUDs to contraceptive implants and injectable contraceptives. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.